GGSOX | RSLDX | GGSOX / RSLDX | |
Total Expense Ratio | 1.27 | 0.80 | 159% |
Annual Report Gross Expense Ratio | 1.27 | 0.80 | 159% |
Fund Existence | 10 years | 9 years | - |
Gain YTD | -5.397 | -5.566 | 97% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 1000 | 250 | 400% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 84.3M | 67.9B | 0% |
Annual Yield % from dividends | 0.00 | 0.89 | - |
Returns for 1 year | -2.30 | -1.63 | 141% |
Returns for 3 years | -13.88 | 2.03 | -682% |
Returns for 5 years | 10.33 | 29.64 | 35% |
Returns for 10 years | N/A | N/A | - |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
EUSA | 91.14 | 1.70 | +1.90% |
iShares MSCI USA Equal Weighted ETF | |||
IBBQ | 20.88 | 0.38 | +1.85% |
Invesco Nasdaq Biotechnology ETF | |||
AIVL | 105.12 | 1.24 | +1.19% |
WisdomTree US Al Enhanced Val ETF | |||
PZT | 21.72 | 0.21 | +0.95% |
Invesco New York AMT-Free Muni Bd ETF | |||
CADNZD | 1.21 | N/A | N/A |
Canadian Dollar - New Zealand Dollar |